Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001121404-22-000018
Filing Date
2022-10-28
Accepted
2022-10-28 11:16:28
Documents
6
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 6-K a6kcoverpagepressreleaseq3.htm 6-K 14779
2 EX-99.1 pressreleaseq32022english.htm EX-99.1 1118729
3 GRAPHIC chart-6387a406886e4caa9ed.jpg GRAPHIC 61971
4 GRAPHIC chart-c3aee8ddf68f4083a75.jpg GRAPHIC 77616
5 GRAPHIC esg251022.jpg GRAPHIC 69329
6 GRAPHIC image.jpg GRAPHIC 4047
  Complete submission text file 0001121404-22-000018.txt   1428478
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 221339788
SIC: 2834 Pharmaceutical Preparations